Tsumura & Co. (4540) · InitiativeFirst stated
Expansion into OTC pharmaceuticals and healthcare through making 養命酒製造 a wholly owned subsidiary
First written in FY2027-H1. . Latest entry: FY2027-H1.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Expansion of the OTC pharmaceuticals and healthcare businesses through the acquisition of YOMEISHU SEIZO CO.,LTD. as a subsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.